Showing results (1-10 of 128) with videos related to
Sort By:
Pageof 13
Therapeutic Innovation & Regulatory Science|June 6, 2020
The Financial Benefits of Faster Development Times: Integrated Formulation Development, Real-Time Manufacturing, and Clinical TestingJoseph A DiMasi, Michael WilkinsonPharmacoeconomics|November 30, 2002
The value of improving the productivity of the drug development process: faster times and better decisionsJoseph A DiMasiAmerican Journal of Therapeutics|September 1, 1996
A New Look At United States Drug Development and Approval TimesJoseph A. DiMasiClinical Therapeutics|June 4, 2013
Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indicationsJoseph A DiMasiAmerican Journal of Therapeutics|January 25, 2013
Pharmaceutical R&D performance by firm size: approval success rates and economic returnsJoseph A DiMasiClinical Pharmacology and Therapeutics|September 11, 2019
Development Times and Approval Success Rates for Drugs to Treat Infectious DiseasesJoseph A DiMasi, Maria I Florez, Stella Stergiopoulos, et al.Pharmacoeconomics|January 22, 2005
The economics of follow-on drug research and development: trends in entry rates and the timing of developmentJoseph A DiMasi, Cherie PaquetteJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2007
Economics of new oncology drug developmentJoseph A DiMasi, Henry G GrabowskiNature Reviews. Drug Discovery|December 15, 2010
Competitiveness in follow-on drug R&D: a race or imitation?Joseph A DiMasi, Laura B FadenPharmacoeconomics|November 30, 2002
Returns on research and development for 1990s new drug introductionsHenry Grabowski, John Vernon, Joseph A DiMasiPageof 13